Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? - Wikidata - thesis-toulmin - TriplyDB

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

http://www.wikidata.org/entity/Q35175404

about

Protein phosphatase 2A dysfunction in Alzheimer's disease Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides Application of artificial neural networks to investigate one-carbon metabolism in Alzheimer's disease and healthy matched individuals A pilot study evaluating the contribution of SLC19A1 (RFC-1) 80G>a polymorphism to Alzheimer's disease in Italian Caucasians.Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice.Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer's disease.The relationship between associative learning, transfer generalization, and homocysteine levels in mild cognitive impairment.High levels of homocysteine results in cerebral amyloid angiopathy in mice Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles Homocysteine Induced Cerebrovascular Dysfunction: A Link to Alzheimer's Disease Etiology Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.Folic Acid Inhibits Amyloid β-Peptide Production through Modulating DNA Methyltransferase Activity in N2a-APP Cells.Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.Association study between the DNMT3A -448A>G polymorphism and risk of Alzheimer's disease in Caucasians of Italian origin Epigenetics-Based Therapeutics for Neurodegenerative Disorders.PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments.Elevated plasma homocysteine level in vascular dementia reflects the vascular disease process Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment Serum Homocysteine, Dehydroepiandrosterone Sulphate and Lipoprotein (a) in Alzheimer's Disease and Vascular Dementia Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors.Homocysteine modulates 5-lipoxygenase expression level via DNA methylation.Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype.Does physical activity reduce risk for Alzheimer's disease through interaction with the stress neuroendocrine system?Brain aging and late-onset Alzheimer's disease: many open questions.The neurotoxicity of nitrous oxide: the facts and "putative" mechanisms.Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.The relationship between hyperhomocysteinemia and neurodegeneration.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells.Further development of biomarkers in amyotrophic lateral sclerosis.Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells.Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.Activation of AMP-activated protein kinase alleviates homocysteine-mediated neurotoxicity in SH-SY5Y cells.Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses.Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity.Is there any relation between pseudoexfoliation syndrome and Alzheimer's type dementia?

P2860

Q21090465-58B268DD-D9D2-4AA2-9F86-74A9FAC3C9E4 Q26799893-492D59C7-F27F-48F1-B519-770353779675 Q28385065-79D7194C-8420-4DC7-80B4-A9ED8ED788B5 Q28535239-9C80696D-6CC8-4012-A3D8-0BF66A456E76 Q33796669-A169E3D9-DBF5-4170-89EC-2AAEEF5607DE Q34077890-3A8D6A3F-7D90-43EB-808C-C39EC80682AC Q34354421-8F6AE2FF-D36F-41C6-8B3D-DFBAD82A2613 Q34431347-DA9783DD-0992-44B4-AE13-F1A03B6E59A2 Q35185043-45C9F191-36CA-4825-9A91-4A175468B0EA Q35185115-5A19862A-D478-4DA1-AF93-A28B4D289C8B Q35796970-2527DB11-7A9D-44B0-8E0E-967FA27C8203 Q36174698-7F1AE96C-C002-4F64-929D-B7994CD5006D Q36247488-ECAC8490-14BC-4130-97D9-9DF641B8DF9B Q36327771-9A45A511-EE96-4376-8F1D-23AD08477650 Q36678669-A8DD5622-F685-4374-BC55-B6F1EB3A6943 Q36697733-CA14500A-8BA8-4410-9DE5-A482650E04C8 Q36742759-32EA827A-361E-4D6D-BD21-0D62E1C11C47 Q36744326-F8D0788C-10E0-4174-B73F-CBDB6AE64EB3 Q36767796-068C79BE-005E-4245-8F7C-9B5C3E1A4B0D Q36798886-17693965-E55C-49DC-B95D-7FB86FA7ACBF Q36859910-058706E8-19A2-4F04-9107-4ED86F58CDDB Q37104293-898481DD-2543-42CD-B0C4-8B70AE0F2BB9 Q37562875-E7A5B53F-B9DC-41DA-87FB-8E6B880ED2BE Q37678192-1AB77DAA-B023-4F5B-9423-C5907D1BBEBF Q37739453-377A4689-E2E4-4D7D-8F01-A34FF2A4FD01 Q37951538-A78C0DB0-C0D6-4A54-B64E-2C9D2D0C6B00 Q38025479-9F35A136-69A7-4BBB-97D3-40B816C382AA Q38222907-E231001D-CCEF-4F3A-8A11-DE79F5411EFF Q38513243-2ADDCD41-57FA-4493-9208-3FA4356AE05C Q38794990-28AE72AC-B474-468C-B133-695E4ECE52F7 Q38847200-CC5EF751-FD05-439A-876E-E7630550C94B Q38847953-75BB174C-D9AF-4E23-816C-829762D80B40 Q38856405-B7B9473A-7626-4C3E-A025-A8D4EBAC714A Q38990987-213528B0-25D3-4773-B663-8E8912323F4D Q39041998-24BF4FB9-9D9C-4A9A-BAAE-8848165A011F Q39159241-AA991784-AB3A-4C62-BE87-FEB3627C772C Q41099743-DD6F5A8C-01D8-40F1-A844-9F82CCDE37AB Q41627968-88C8F4EE-888F-4B68-B51B-2E20E9FE2E51 Q46041979-4B2831F4-5137-4ECC-9F5F-7770BF03DFD4 Q46091488-F4A41300-1E21-4E40-983C-DEA7FD829B26

P2860

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

http://www.wikidata.org/entity/Q35175404

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@ast

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@en

type

label

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@ast

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@en

prefLabel

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@ast

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@en

P1433

Q35175404-EDB32B04-AE83-4CAC-B30E-2DBA971CB1DD

P1476

Q35175404-DAA062EE-83F5-4EED-A595-DE7A3B35450C

P2093

Q35175404-0B714D8D-4E46-4176-B457-3887F94AA19E

Q35175404-5FE06912-3C74-423C-8A2A-C68EAEC47ABD

Q35175404-8FD507D5-50A3-4686-8CCD-415F62077A71

P2860

Q35175404-001D1DAF-0B4D-432C-AC57-C9F6AADFFE54

Q35175404-02DDB076-06EF-414A-83CD-A0BCA0D3471D

Q35175404-07FD18D9-4483-4637-9727-908D595891D9

Q35175404-080224C1-253C-42EC-AEA8-406C5F9D5640

Q35175404-0AD5736D-DFA8-4087-85C3-99BB033B9052

Q35175404-0BAE683B-5C94-4CCC-864C-4D3115116420

Q35175404-0EF91ED3-DB59-4F21-891A-46F1E8116A42

Q35175404-11F27A61-6129-4B4F-9367-8EA5B50A1274

Q35175404-147CB396-710B-479A-A7D8-C7EEFEF2574E

Q35175404-1713E0D5-33AC-4E27-864E-A61231FA83FA

P304

Q35175404-DDDEC74E-EBBB-464C-8986-20ECD22B01B2

P31

Q35175404-FF2555CA-8CF6-4CAD-A64A-C7439FC12268

P356

Q35175404-9236808A-1E18-4F38-A9C6-11A4FCDD09A9

P433

Q35175404-3FD53994-E397-4D25-A7CC-B37FAF12A3A6

P478

Q35175404-6E53C07A-64B8-4ACD-9753-E0A96B7EFD66

P577

Q35175404-55F6D0B3-F61F-49E3-A9D2-E2C8FDF0DA04

P5875

Q35175404-405F5378-DDC7-4071-9CA3-AB4C88E1B05A

P698

Q35175404-44198462-193D-4AF7-9F38-690AA7C51481

P921

Q35175404-3B575886-4222-40EB-B750-52F7A33E1484

Q35175404-A45EDF48-9238-4F79-A972-77EBDBE18C4E

P932

Q35175404-0954FC32-4AF3-499D-A295-9E8CAF9E4B3A

P356

J.TIPS.2011.05.003

P1433

Trends in Pharmacological Sciences

P1476

Is hyperhomocysteinemia an Alz ...... tor, an AD marker, or neither?

@en

P2093

Domenico Praticò

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Jia-Min Zhuo

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of Alzheimer's disease with anti-homocysteic acid antibody in 3xTg-AD male mice

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Forecasting the global burden of Alzheimer’s disease

Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress

Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits

Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet

Homocystamides promote free-radical and oxidative damage to proteins

The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine

Homocysteine and Alzheimer's disease

Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice

P304

562-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TIPS.2011.05.003

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51229512

http://www.w3.org/2001/XMLSchema#string

P698

21684021

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3159702

http://www.w3.org/2001/XMLSchema#string